anemia

The method allows clinicians to more easily integrate anemia testing with testing for other underlying disorders, potentially aiding study of the condition.

The CDC received clearance for a number of influenza panels and kits. Agilent's assay for postnatal CNV detection, and Abbott's hematocrit test were also cleared. 

The kit is designed to be used on the same platform as Grifols' other molecular typing platforms and can provide results within four hours of DNA extraction.